rituximab
not tagged
[]
ielsg37 study. mediastinal rt safely ommited in patients with pmbcl in cmr after first line. the largest randomized trial in pmbcl.
less orr after r-chop21 induction.#icml 
Hematologist Hematology and Oncology Institute Donostia